1. Yoshida A, Tsuta K, Watanabe S, Sekine I, Fukayama M, Tsuda H, et al. Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component. Lung Cancer. 2011; 72:309–15.
Article
2. Kastelik JA. Management of malignant pleural effusion. Lung. 2013; 191:165–75.
Article
3. Maeda H, Okabayashi T, Nishimori I, Sugimoto T, Namikawa T, Dabanaka K, et al. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach? J Am Coll Surg. 2008; 206:306–10.
Article
4. Kim JY, Lee HS, Kim N, Shin CM, Lee SH, Park YS, et al. Prevalence and clinicopathologic characteristics of gastric cardia cancer in South Korea. Helicobacter. 2012; 17:358–68.
Article
5. Taghavi S, Jayarajan SN, Davey A, Willis AI. Prognostic significance of signet ring gastric cancer. J Clin Oncol. 2012; 30:3493–8.
Article
6. Cheung TC, Ng FH, Chow KC, Maw CK, Ng WF. Occult gastric cancer presenting as cor pulmonale resulting from tumor cell microembolism. Am J Gastroenterol. 1997; 92:1057–9.
7. Desigan G, Wang M, Wofford B, Dunn GD, Vaughan S. Occult gastric cancer manifested by progressive shortness of breath in a young adult. South Med J. 1986; 79:1173–6.
Article
8. Nguyen VX, Nguyen BD, Ram PC. Occult colon cancer with initial cutaneous metastatic manifestation: PET/CT detection. Clin Nucl Med. 2012; 37:506–8.
9. Patel P, Finger PT. Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis. Am J Ophthalmol. 2012; 153:661–8.
Article
10. Han A, Xue J, Hu M, Zheng J, Wang X. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. Cancer Epidemiol. 2012; 36:470–5.
Article